No coin nor oath required. For personal study only.
has completed the acquisition of the worldwide business of Lancaster Synthesis Ltd from Clariant AG for ยฃ2 M. On 27 Jul 2004, prior to the completion of the acquisition, there was a serious fire at Lancaster's UK premises, which resulted in the destruction of its pilot scale manufacturing plant and the loss of most of its stock. JM and Clariant subsequently entered into, and have now concluded, negotiations to modify the terms of the proposed acquisition of Lancaster to reflect the impact of the fire on the Lancaster business.
๐ SIMILAR VOLUMES
4Q 2004), while revenue for 2005 was $2.7 bn (24% over $2.2 bn in 2004). R&D expenses were $138.186 M for 4Q 2005 ($107.428 M in 4Q 2004). For 2005, R&D expenses were $502.657 M ($391.802 M in 2004). Genzyme confirmed the revenue and earnings guidance for 2006 that it provided in Jan 2006.